Exchange: NASDAQ·Updated 07:11 PM EDT

TRML Tourmaline Bio Inc

$47.98
$0.00
(0.00%)
Today
Closed $47.98
$0.0101
(0.02%)
After Hours
Reported EarningsAug 13
Mkt Cap$1.23B
Vol783,730.00

About TRML

Tourmaline Bio, Inc. is a late-stage clinical biotechnology company, which engages in the development of medicines for patients with life-altering immune diseases. It offers the TOUR006. The company was founded by Sandeep Kulkarni on September 17, 2021 and is headquartered in New York, NY.
50

Neutral Sentiment

How do you feel about TRML?

Advertisement|Remove ads.